These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 32334034)

  • 1. Phase 1 Trial of Concurrent Gemcitabine and Cisplatin with Image Guided Intensity Modulated Radiation Therapy for Locoregionally Advanced Cervical Carcinoma.
    Mell LK; Xu R; Yashar CM; McHale MT; Einck JP; Mayadev J; Lee E; Binder P; Rash D; Eskander R; Heide ES; Plaxe SC; Mundt AJ; Saenz CC
    Int J Radiat Oncol Biol Phys; 2020 Aug; 107(5):964-973. PubMed ID: 32334034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Image Guidance Volume-Modulated Arc Radiation Therapy Concurrently With Nab-Paclitaxel Plus Cisplatin for Patients With Locally Advanced Cervical Cancer: A Single-Arm Dose Escalation Trial.
    Jiang P; Deng X; Qu A; Jiang W; Guo F; Han Q; Guo H; Wang J
    Int J Radiat Oncol Biol Phys; 2023 Apr; 115(5):1197-1204. PubMed ID: 36402358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase I study of gemcitabine followed by cisplatin concurrent with whole pelvic radiation therapy in locally advanced cervical cancer: a Gynecologic Oncology Group study.
    Rose PG; Degeest K; McMeekin S; Fusco N
    Gynecol Oncol; 2007 Nov; 107(2):274-9. PubMed ID: 17688925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positron Emission Tomography-Guided Bone Marrow-Sparing Radiation Therapy for Locoregionally Advanced Cervix Cancer: Final Results From the INTERTECC Phase II/III Trial.
    Williamson CW; Sirák I; Xu R; Portelance L; Wei L; Tarnawski R; Mahantshetty U; Heide ES; Yashar CM; McHale MT; Bosch W; Lowenstein J; Saenz CC; Plaxe S; Eskander R; Einck J; Mundt AJ; Mayadev J; Mell LK
    Int J Radiat Oncol Biol Phys; 2022 Jan; 112(1):169-178. PubMed ID: 34419564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hematologic toxicity in RTOG 0418: a phase 2 study of postoperative IMRT for gynecologic cancer.
    Klopp AH; Moughan J; Portelance L; Miller BE; Salehpour MR; Hildebrandt E; Nuanjing J; D'Souza D; Souhami L; Small W; Gaur R; Jhingran A
    Int J Radiat Oncol Biol Phys; 2013 May; 86(1):83-90. PubMed ID: 23582248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone Marrow-sparing Intensity Modulated Radiation Therapy With Concurrent Cisplatin For Stage IB-IVA Cervical Cancer: An International Multicenter Phase II Clinical Trial (INTERTECC-2).
    Mell LK; Sirák I; Wei L; Tarnawski R; Mahantshetty U; Yashar CM; McHale MT; Xu R; Honerkamp-Smith G; Carmona R; Wright M; Williamson CW; Kasaová L; Li N; Kry S; Michalski J; Bosch W; Straube W; Schwarz J; Lowenstein J; Jiang SB; Saenz CC; Plaxe S; Einck J; Khorprasert C; Koonings P; Harrison T; Shi M; Mundt AJ;
    Int J Radiat Oncol Biol Phys; 2017 Mar; 97(3):536-545. PubMed ID: 28126303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concurrent cisplatin/gemcitabine chemotherapy along with radiotherapy in locally advanced cervical carcinoma: a phase II trial.
    Umanzor J; Aguiluz M; Pineda C; Andrade S; Erazo M; Flores C; Santillana S
    Gynecol Oncol; 2006 Jan; 100(1):70-5. PubMed ID: 16288803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of semiextended field intensity-modulated radiation therapy and concurrent cisplatin in locally advanced cervical cancer patients: An observational study of 10-year experience.
    Lee J; Lin JB; Sun FJ; Chen YJ; Chang CL; Jan YT; Wu MH
    Medicine (Baltimore); 2017 Mar; 96(10):e6158. PubMed ID: 28272204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Weekly gemcitabine and cisplatin in combination with pelvic radiation in the primary therapy of cervical cancer: a phase I trial of the Puget Sound Oncology Consortium.
    ; Swisher EM; Swensen RE; Greer B; Tamimi H; Goff BA; Garcia R; Koh WJ
    Gynecol Oncol; 2006 Jun; 101(3):429-35. PubMed ID: 16337995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase I-II study of weekly cisplatin and gemcitabine with concurrent radiotherapy in locally advanced cervical carcinoma.
    Zarbá JJ; Jaremtchuk AV; Gonzalez Jazey P; Keropian M; Castagnino R; Mina C; Arroyo G;
    Ann Oncol; 2003 Aug; 14(8):1285-90. PubMed ID: 12881394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Weekly gemcitabine and cisplatin concurrent with pelvic irradiation for primary therapy of cervical cancer: report of the first seven cases in Thai women.
    Chumworathayi B; Yuenyao P; Tangvorapongchai V; Luanratanakorn S; Pattamadilok J; Krusun S
    Radiat Med; 2007 Nov; 25(9):474-9. PubMed ID: 18026906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase I study of concurrent weekly carboplatin and paclitaxel combined with intensity-modulated pelvic radiotherapy as an adjuvant treatment for early-stage cervical cancer patients with positive pelvic lymph nodes.
    Mabuchi S; Takahashi R; Isohashi F; Yokoi T; Ito K; Tsutui T; Ogata T; Yoshioka Y; Ogawa K; Kimura T
    Int J Gynecol Cancer; 2013 Sep; 23(7):1279-86. PubMed ID: 23835505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term results of a phase II study of gemcitabine and cisplatin chemotherapy combined with intensity-modulated radiotherapy in locoregionally advanced nasopharyngeal carcinoma.
    Wu M; Ou D; He X; Hu C
    Oral Oncol; 2017 Oct; 73():118-123. PubMed ID: 28939063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathologic response and toxicity assessment of chemoradiotherapy with cisplatin versus cisplatin plus gemcitabine in cervical cancer: a randomized Phase II study.
    Dueñas-González A; Cetina-Perez L; Lopez-Graniel C; Gonzalez-Enciso A; Gómez-Gonzalez E; Rivera-Rubi L; Montalvo-Esquivel G; Muñoz-Gonzalez D; Robles-Flores J; Vazquez-Govea E; de La Garza J; Mohar A
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):817-23. PubMed ID: 15708261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoadjuvant Chemotherapy With Cisplatin and Gemcitabine Followed by Chemoradiation Versus Chemoradiation for Locally Advanced Cervical Cancer: A Randomized Phase II Trial.
    da Costa SCS; Bonadio RC; Gabrielli FCG; Aranha AS; Dias Genta MLN; Miranda VC; de Freitas D; Abdo Filho E; Ferreira PAO; Machado KK; Scaranti M; Carvalho HA; Estevez-Diz MDP
    J Clin Oncol; 2019 Nov; 37(33):3124-3131. PubMed ID: 31449470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase III, open-label, randomized study comparing concurrent gemcitabine plus cisplatin and radiation followed by adjuvant gemcitabine and cisplatin versus concurrent cisplatin and radiation in patients with stage IIB to IVA carcinoma of the cervix.
    Dueñas-González A; Zarbá JJ; Patel F; Alcedo JC; Beslija S; Casanova L; Pattaranutaporn P; Hameed S; Blair JM; Barraclough H; Orlando M
    J Clin Oncol; 2011 May; 29(13):1678-85. PubMed ID: 21444871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early clinical outcomes and toxicity of intensity modulated versus conventional pelvic radiation therapy for locally advanced cervix carcinoma: a prospective randomized study.
    Gandhi AK; Sharma DN; Rath GK; Julka PK; Subramani V; Sharma S; Manigandan D; Laviraj MA; Kumar S; Thulkar S
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):542-8. PubMed ID: 24074927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experience with combination of cisplatin plus gemcitabine chemotherapy and intensity-modulated radiotherapy for locoregionally advanced nasopharyngeal carcinoma.
    He X; Ou D; Ying H; Zhu G; Hu C; Liu T
    Eur Arch Otorhinolaryngol; 2012 Mar; 269(3):1027-33. PubMed ID: 21706324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I study of concomitant gemcitabine and IMRT for patients with unresectable adenocarcinoma of the pancreatic head.
    Crane CH; Antolak JA; Rosen II; Forster KM; Evans DB; Janjan NA; Charnsangavej C; Pisters PW; Lenzi R; Papagikos MA; Wolff RA
    Int J Gastrointest Cancer; 2001; 30(3):123-32. PubMed ID: 12540024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gemcitabine, cisplatin, and hyperfractionated accelerated radiotherapy for locally advanced non-small cell lung cancer.
    Zwitter M; Kovac V; Smrdel U; Strojan P
    J Thorac Oncol; 2006 Sep; 1(7):662-6. PubMed ID: 17409933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.